Literature DB >> 3777174

Gallbladder prostaglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis.

W W LaMorte, J T LaMont, W Hale, M L Booker, T E Scott, B Turner.   

Abstract

Mucin hypersecretion from the gallbladder epithelium contributes to cholesterol gallstone formation by accelerating the nucleation of cholesterol-supersaturated bile. Prostaglandins (PGs) and lysophosphatidylcholine (LPC) have both been implicated as potential mediators of mucin hypersecretion, but their roles are unclear. We fed prairie dogs a lithogenic diet (0.34% cholesterol), and after 1, 2, 4, or 6 wk of cholesterol feeding, we measured glycoprotein and LPC concentrations in bile and PG synthesis in gallbladder and liver slices. Hypercholesterolemia and cholesterol supersaturation of bile occurred after 1 wk of cholesterol feeding, but marked crystal formation was delayed until 4 wk, when glycoprotein concentrations became markedly elevated. Glycoprotein hypersecretion was preceded by increased synthesis of PGF2 alpha (P less than 0.002), PGE2 (P less than 0.001), prostacyclin (P less than 0.05), and thromboxane (P = 0.07) in the gallbladder after only 2 wk of cholesterol feeding, but PG synthesis in the liver remained unchanged (P greater than 0.14). LPC concentrations in gallbladder bile also increased at 2 wk (P less than 0.02), but LPC in hepatic bile was unchanged (P = 0.35). In organ culture studies, LPC caused a dose-dependent stimulation of [3H]glycoprotein release from guinea pig gallbladder mucosa that could not be explained solely by LPC's detergent properties. We conclude that gallbladder PG synthesis and LPC production are increased at an early stage of cholesterol gallstone formation in the prairie dog model. These changes probably play a significant role in gallstone pathogenesis, since they mediate hypersecretion of gallbladder mucin and thus favor the nucleation of cholesterol-supersaturated bile.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777174     DOI: 10.1152/ajpgi.1986.251.5.G701

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.

Authors:  J W Marks; G G Bonorris; L J Schoenfield
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats.

Authors:  I Castagliuolo; S E Leeman; E Bartolak-Suki; S Nikulasson; B Qiu; R E Carraway; C Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.

Authors:  P Janowitz; W Swobodnik; J G Wechsler; A Janowitz; D Saal; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1991-05-03

4.  Differential effect of prostaglandins on gallstone-free and gallstone-containing human gallbladder.

Authors:  R R Greaves; L J O'Donnell; M J Farthing
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

5.  Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor.

Authors:  B A Chapman; M J Burt; R J Chisholm; R B Allan; K H Yeo; A G Ross
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Authors:  C Pothoulakis; I Castagliuolo; J T LaMont; A Jaffer; J C O'Keane; R M Snider; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Cyclooxygenase-2 mediates mucin secretion from epithelial cells of lipopolysaccharide-treated canine gallbladder.

Authors:  Hong-Ja Kim; Sung-Koo Lee; Myung-Hwan Kim; Dong-Wan Seo; Young-Ii Min
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

8.  Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.

Authors:  M Rhodes; A Allen; R H Dowling; G Murphy; T W Lennard
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

9.  Gallbladder mucosal protein secretion during development of experimental cholecystitis.

Authors:  D L Kaminski; Y G Deshpande; A Li; F Dysart; M Nag
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

10.  Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog.

Authors:  M L Booker; T E Scott; W W La Morte
Journal:  Lipids       Date:  1990-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.